Fidmi Medical

Company Overview

Snapshot

Founded in October 2014 by Ishay Benuri, Fidmi Medical operates with 1–10 employees. The company has raised $4.85 million across four funding rounds from four investors. In October 2021, Fidmi Medical launched U.S. sales of its novel low-profile PEG device and secured additional funding.

Business overview

Fidmi Medical develops enhanced enteral feeding devices designed for easy insertion, replacement, and removal. Its core technology is a low-profile PEG device that aims to reduce clogging and eliminate the need for frequent replacements. The device integrates a flexible, rigid-core internal bumper for secure placement and trauma-free removal, a disposable feeding tube for easy replacement, and a flexible external retention bumper for stoma protection and enhanced fit. Fidmi Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Life Support, serving healthcare providers and patients globally, including in the United States and China.

Strategic signal

In October 2021, Fidmi Medical launched U.S. sales of its novel low-profile PEG device, marking a significant commercialization milestone. This move indicates the company's transition from product development to market penetration, validating its technology and expanding its reach into a critical healthcare market. For investors, this signals strong progress in commercial strategy and potential for revenue growth.

Company Intelligence Q&A

When did Fidmi Medical receive FDA regulatory clearance for its low-profile enteral feeding device?

In October 2019, Fidmi Medical received 510K regulatory clearance from the FDA for its low-profile enteral feeding device, enabling its commercialization in the United States.

What was a significant funding event for Fidmi Medical in 2017?

In September 2017, Fidmi Medical raised funding from B. Braun Melsungen AG, a strategic investment that supported the company's development of enhanced feeding devices.

What strategic collaboration did Fidmi Medical announce in September 2019?

In September 2019, Fidmi Medical announced a collaboration with CoapTech to work on groundbreaking G-Tube systems, aiming to advance enteral feeding solutions.

When did Fidmi Medical launch U.S. sales of its novel low-profile PEG device?

In October 2021, Fidmi Medical launched U.S. sales of its novel low-profile PEG device, expanding its market reach and commercial activities.

Which investor participated in Fidmi Medical's funding round in October 2021?

In October 2021, The Trendlines Group participated in a funding round for Fidmi Medical, continuing its support for the company's growth and market expansion.